564 related articles for article (PubMed ID: 34661893)
1. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.
Yasmin H; Saha S; Butt MT; Modi RK; George AJT; Kishore U
Adv Exp Med Biol; 2021; 1313():99-134. PubMed ID: 34661893
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
3. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?
Wang Z; Zhou M; Fu Z; Zhao L
Front Immunol; 2021; 12():693579. PubMed ID: 34335604
[TBL] [Abstract][Full Text] [Related]
4. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.
Gadi N; Wu SC; Spihlman AP; Moulton VR
Front Immunol; 2020; 11():2147. PubMed ID: 32983176
[TBL] [Abstract][Full Text] [Related]
5. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
[TBL] [Abstract][Full Text] [Related]
6. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
7. Infection Prevention Precautions for Routine Anesthesia Care During the SARS-CoV-2 Pandemic.
Bowdle A; Jelacic S; Shishido S; Munoz-Price LS
Anesth Analg; 2020 Nov; 131(5):1342-1354. PubMed ID: 33079853
[TBL] [Abstract][Full Text] [Related]
8. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of SARS-CoV-2.
Dërmaku-Sopjani M; Sopjani M
Curr Mol Med; 2021; 21(7):589-595. PubMed ID: 33272175
[TBL] [Abstract][Full Text] [Related]
10. [Interaction between SARS-CoV-2 and Host Innate Immunity].
Duan XQ; Xie H; Chen LM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
[TBL] [Abstract][Full Text] [Related]
11. Novel coronavirus pandemic: A clinical overview.
Kaswa R; Govender I
S Afr Fam Pract (2004); 2020 Jun; 62(1):e1-e5. PubMed ID: 32633997
[TBL] [Abstract][Full Text] [Related]
12. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
Zhang F; Gan R; Zhen Z; Hu X; Li X; Zhou F; Liu Y; Chen C; Xie S; Zhang B; Wu X; Huang Z
Signal Transduct Target Ther; 2020 Aug; 5(1):156. PubMed ID: 32796814
[TBL] [Abstract][Full Text] [Related]
13. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
15. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
Kouwaki T; Nishimura T; Wang G; Oshiumi H
Front Immunol; 2021; 12():700926. PubMed ID: 34249006
[TBL] [Abstract][Full Text] [Related]
16. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.
Shen J; Fan J; Zhao Y; Jiang D; Niu Z; Zhang Z; Cao G
Front Immunol; 2023; 14():1159326. PubMed ID: 37228604
[TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis, and Investigational Therapeuti.
Sharma R; Khokhar D; Gupta B; Saxena P; Ghosh KK; Geda AK; Kuca K
Curr Med Chem; 2021; 28(41):8559-8594. PubMed ID: 33949925
[TBL] [Abstract][Full Text] [Related]
18. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
[TBL] [Abstract][Full Text] [Related]
19. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
[TBL] [Abstract][Full Text] [Related]
20. The Immune Responses against Coronavirus Infections: Friend or Foe?
Vafaeinezhad A; Atashzar MR; Baharlou R
Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
